Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 1.000 | |
4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.594 | |
3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.592 | |
3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.589 | |
3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.581 | |
3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.568 | |
3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.565 | |
1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.564 | |
3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.561 | |
3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.561 | |
3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.550 | |
3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.549 | |
3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.546 | |
4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.544 | |
2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.543 | |
3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.543 | |
1byg | STU | Tyrosine-protein kinase CSK | / | 0.538 | |
2c0o | L2G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.533 | |
2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.531 | |
2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.530 | |
3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.530 | |
1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.528 | |
4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.528 | |
1u54 | ACP | Activated CDC42 kinase 1 | / | 0.521 | |
3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.520 | |
3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.520 | |
3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.519 | |
2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.518 | |
4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.517 | |
5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.517 | |
2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.515 | |
3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.515 | |
1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.507 | |
4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.507 | |
2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.505 | |
4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.504 | |
5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.504 | |
1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.503 | |
4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.501 | |
3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.499 | |
1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.495 | |
2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.494 | |
3bu5 | ATP | Insulin receptor | 2.7.10.1 | 0.494 | |
3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.494 | |
4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.494 | |
2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.493 | |
3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.493 | |
4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.493 | |
4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.493 | |
4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.493 | |
2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.492 | |
2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.492 | |
2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.492 | |
2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.492 | |
4dym | IYZ | Activin receptor type-1 | 2.7.11.30 | 0.491 | |
1xr1 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.490 | |
2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.490 | |
3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.490 | |
4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.490 | |
2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.489 | |
1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.488 | |
2phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.488 | |
3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.488 | |
4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.488 | |
1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.487 | |
3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.487 | |
3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.485 | |
4hjo | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.485 | |
4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.485 | |
4utd | ACP | Aurora kinase A | 2.7.11.1 | 0.484 | |
2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.483 | |
4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.483 | |
4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.483 | |
2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.482 | |
4otw | DB8 | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.482 | |
1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.481 | |
3v5j | 0F2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.481 | |
3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.481 | |
1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.479 | |
2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.479 | |
3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.479 | |
4bb4 | 32W | Ephrin type-B receptor 4 | 2.7.10.1 | 0.479 | |
4dit | 0KD | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.478 | |
2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.477 | |
4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.477 | |
3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.476 | |
3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.476 | |
4feq | 0T8 | Tyrosine-protein kinase receptor TYRO3 | 2.7.10.1 | 0.476 | |
4xlv | ACP | Insulin receptor | 2.7.10.1 | 0.476 | |
2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.475 | |
2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.475 | |
2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.475 | |
4c57 | FEF | Cyclin-G-associated kinase | 2.7.11.1 | 0.475 | |
1ie4 | T44 | Transthyretin | / | 0.474 | |
1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 0.474 | |
2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.474 | |
4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.474 | |
2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.473 | |
2yn8 | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.473 | |
4jbp | YPH | Aurora kinase A | 2.7.11.1 | 0.473 | |
2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.472 | |
4o0u | ADN | Aurora kinase A | 2.7.11.1 | 0.472 | |
3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.471 | |
4c58 | 824 | Cyclin-G-associated kinase | 2.7.11.1 | 0.471 | |
5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.471 | |
4bbf | O19 | Tyrosine-protein kinase JAK2 | / | 0.470 | |
4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.470 | |
4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.470 | |
2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.469 | |
2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.469 | |
4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.469 | |
4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.469 | |
2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.468 | |
2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.468 | |
2xch | CKG | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.468 | |
3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.468 | |
3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.468 | |
4wsq | KSA | AP2-associated protein kinase 1 | 2.7.11.1 | 0.468 | |
4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.468 | |
1rw8 | 580 | TGF-beta receptor type-1 | 2.7.11.30 | 0.467 | |
2zv9 | PP2 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.467 | |
3hmm | 855 | TGF-beta receptor type-1 | 2.7.11.30 | 0.467 | |
4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.467 | |
2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.466 | |
4gfo | 0X2 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.466 | |
4m69 | ANP | Receptor-interacting serine/threonine-protein kinase 3 | 2.7.11.1 | 0.466 | |
4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.466 | |
2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.465 | |
3orm | AGS | Serine/threonine protein kinase | / | 0.465 | |
3q4z | ANP | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.465 | |
3tti | KBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.465 | |
3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.465 | |
4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.465 | |
4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.465 | |
3ori | AGS | Serine/threonine protein kinase | / | 0.464 | |
4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.464 | |
4zse | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.464 | |
2i4j | DRJ | Peroxisome proliferator-activated receptor gamma | / | 0.463 | |
1uu3 | LY4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.462 | |
1yi3 | LY2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.462 | |
2pz5 | ACP | Fibroblast growth factor receptor 2 | / | 0.462 | |
2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.462 | |
3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.462 | |
4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.462 | |
2cdz | 23D | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.461 | |
2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.461 | |
2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.461 | |
2vx1 | 7X8 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.461 | |
2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.461 | |
2ycs | NXP | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.461 | |
3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.461 | |
4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.461 | |
5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.461 | |
2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.460 | |
2pzp | ACP | Fibroblast growth factor receptor 2 | / | 0.460 | |
2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.460 | |
2zm1 | KSF | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.460 | |
3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.460 | |
4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.460 | |
4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.460 | |
2wmq | ZYQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
2x2m | X2M | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.459 | |
3bkb | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.459 | |
4jr3 | KJR | Epidermal growth factor receptor | 2.7.10.1 | 0.459 | |
5dr9 | SKE | Aurora kinase A | 2.7.11.1 | 0.459 | |
1yvj | 4ST | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.458 | |
3ggf | GVD | Serine/threonine-protein kinase 26 | / | 0.458 | |
4ftk | H9K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.458 | |
4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.458 | |
5csh | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.458 | |
2c3k | ABO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.457 | |
2zyb | KSL | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.457 | |
3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.457 | |
3cqe | P91 | Wee1-like protein kinase | 2.7.10.2 | 0.457 | |
3k5u | PFQ | Aurora kinase A | 2.7.11.1 | 0.457 | |
3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.457 | |
3tqh | NDP | Quinone oxidoreductase | / | 0.457 | |
3w18 | N13 | Aurora kinase A | 2.7.11.1 | 0.457 | |
4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.457 | |
4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.457 | |
4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.457 | |
5e8y | STU | TGF-beta receptor type-2 | 2.7.11.30 | 0.457 | |
5e92 | ANP | TGF-beta receptor type-2 | 2.7.11.30 | 0.457 | |
1stc | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.456 | |
2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.456 | |
2qo7 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.456 | |
2w2l | NAD | D-mandelate dehydrogenase | / | 0.456 | |
3zc6 | VFC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.456 | |
4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.456 | |
4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.456 | |
4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.456 | |
1aq1 | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
2eb3 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.455 | |
2obj | VRV | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.455 | |
2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.455 | |
3a60 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.455 | |
3jxw | LXG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.455 | |
4acc | 7YG | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.455 | |
4cd0 | AWJ | ALK tyrosine kinase receptor | 2.7.10.1 | 0.455 | |
4l52 | 1UL | Mitogen-activated protein kinase kinase kinase 7 | 2.7.11.25 | 0.455 | |
4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.455 | |
4oav | ACP | 2-5A-dependent ribonuclease | 3.1.26 | 0.455 | |
5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.455 | |
5drd | ATP | Aurora kinase A | 2.7.11.1 | 0.455 | |
2b1p | AIZ | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.454 | |
2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.454 | |
2ivv | PP1 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.454 | |
3igo | ANP | Calmodulin-domain protein kinase 1, putative | / | 0.454 | |
4enx | Z20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.454 | |
4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.454 | |
1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.453 | |
2v7a | 627 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.453 | |
3apf | BMW | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.453 | |
3r9d | X6B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
4kik | KSA | Inhibitor of nuclear factor kappa-B kinase subunit beta | 2.7.11.10 | 0.452 | |
4q5j | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.452 | |
4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.452 | |
5auw | QUE | Death-associated protein kinase 1 | 2.7.11.1 | 0.452 | |
1ir3 | ANP | Insulin receptor | 2.7.10.1 | 0.451 | |
1y57 | MPZ | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.451 | |
2i4p | DRH | Peroxisome proliferator-activated receptor gamma | / | 0.451 | |
3el8 | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.451 | |
3vth | APC | Carbamoyltransferase | / | 0.451 | |
4a06 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.451 | |
4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.451 | |
4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.451 | |
1ol5 | ADP | Aurora kinase A | 2.7.11.1 | 0.450 | |
2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.450 | |
2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.450 | |
2yiq | YIQ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.450 | |
3c7q | XIN | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.450 | |
3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.450 | |
3sc1 | 3S1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.450 | |
4k0y | 1OA | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.450 | |
4oa9 | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.450 | |
4y95 | 746 | Tyrosine-protein kinase | / | 0.450 | |
1pkg | ADP | Mast/stem cell growth factor receptor Kit | 2.7.10.1 | 0.449 | |
2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.449 | |
2vww | 7X2 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.449 | |
2w7x | D1A | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.449 | |
3ac3 | KSH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.449 | |
3ma3 | 01I | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.449 | |
3t8o | ATP | Rhodopsin kinase | / | 0.449 | |
4fl1 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.449 | |
4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.449 | |
4gih | 0X5 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.449 | |
4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.449 | |
2cgx | 3D3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.448 | |
2xbj | XBJ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.448 | |
2xf0 | 4UB | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
3nlb | 5BE | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
3r6s | CMP | CRP-like cAMP-activated global transcriptional regulator | / | 0.448 | |
3tkh | 07S | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.448 | |
1h1w | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.447 | |
2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.447 | |
2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.447 | |
2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
3umx | Q18 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.447 | |
4fsq | HK3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
4ftj | H8K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
1o6y | ACP | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.446 | |
2brh | DFW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
2pvn | P63 | Casein kinase II subunit alpha | 2.7.11.1 | 0.446 | |
2vz6 | FEF | Calcium/calmodulin-dependent protein kinase type II subunit alpha | 2.7.11.17 | 0.446 | |
2xng | A0H | Aurora kinase A | 2.7.11.1 | 0.446 | |
3ckx | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.446 | |
3crz | FAD | Ferredoxin--NADP+ reductase | / | 0.446 | |
3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.446 | |
4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.446 | |
4fsm | HK1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
4ft0 | HK9 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
4jbq | VX6 | Aurora kinase A | 2.7.11.1 | 0.446 | |
2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.445 | |
2rio | ADP | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.445 | |
2w05 | FRT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.445 | |
3e8e | G98 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.445 | |
3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.445 | |
3i59 | N6S | CRP-like cAMP-activated global transcriptional regulator | / | 0.445 | |
4eor | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
4oau | ADP | 2-5A-dependent ribonuclease | 3.1.26 | 0.445 | |
5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.445 | |
1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.444 | |
2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.444 | |
2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.444 | |
3ac1 | KZI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.444 | |
3ac5 | KZM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.444 | |
1ol7 | ADP | Aurora kinase A | 2.7.11.1 | 0.443 | |
2h96 | 893 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.443 | |
2wms | ZYS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
2ycf | YCF | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.443 | |
3cr0 | 809 | Wee1-like protein kinase | 2.7.10.2 | 0.443 | |
3eb0 | DRK | Uncharacterized protein | / | 0.443 | |
3hx4 | ANP | Calmodulin-domain protein kinase 1 | / | 0.443 | |
3mfu | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.443 | |
4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
4hle | 17V | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.443 | |
4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 | 0.443 | |
1nvr | STU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
1nvs | UCM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.442 | |
2b9f | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.442 | |
2br1 | PFP | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
3du8 | 553 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.442 | |
3jy0 | LYG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.442 | |
3vt7 | VDX | Vitamin D3 receptor | / | 0.442 | |
3w2r | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.442 | |
3zdi | UGJ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.442 | |
4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.442 | |
4b0g | VEK | Aurora kinase A | 2.7.11.1 | 0.442 | |
4dfl | 0K0 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.442 | |
4ez5 | 0RS | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.442 | |
5ar4 | SB2 | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.442 | |
1qpe | PP2 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.441 | |
2np8 | CC3 | Aurora kinase A | 2.7.11.1 | 0.441 | |
2w1e | L0E | Aurora kinase A | 2.7.11.1 | 0.441 | |
2wle | COA | Polysialic acid O-acetyltransferase | / | 0.441 | |
2wqe | ADP | Aurora kinase A | 2.7.11.1 | 0.441 | |
2x2l | X2L | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.441 | |
3wec | AUI | Cytochrome P450 | / | 0.441 | |
3wow | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.441 | |
1h1s | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
1sn5 | T3 | Transthyretin | / | 0.440 | |
2x2k | X2K | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.440 | |
3ad6 | KSC | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.440 | |
3cyl | VIT | Basic phospholipase A2 homolog piratoxin-2 | / | 0.440 | |
4dn5 | AGS | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.440 | |
4fsu | HK5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
4gvj | ADP | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.440 |